UniProt ID | CHM4B_HUMAN | |
---|---|---|
UniProt AC | Q9H444 | |
Protein Name | Charged multivesicular body protein 4b | |
Gene Name | CHMP4B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 224 | |
Subcellular Localization |
Cytoplasm, cytosol . Late endosome membrane Peripheral membrane protein . Midbody . Nucleus envelope . Recruited to the nuclear envelope by CHMP7 during late anaphase (PubMed:26040712). Localizes transiently to the midbody arms immediately before a |
|
Protein Description | Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. [PubMed: 12860994] | |
Protein Sequence | MSVFGKLFGAGGGKAGKGGPTPQEAIQRLRDTEEMLSKKQEFLEKKIEQELTAAKKHGTKNKRAALQALKRKKRYEKQLAQIDGTLSTIEFQREALENANTNTEVLKNMGYAAKAMKAAHDNMDIDKVDELMQDIADQQELAEEISTAISKPVGFGEEFDEDELMAELEELEQEELDKNLLEISGPETVPLPNVPSIALPSKPAKKKEEEDDDMKELENWAGSM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSVFGKLFG ------CCHHHHCCC | 26.59 | 24719451 | |
2 | Acetylation | ------MSVFGKLFG ------CCHHHHCCC | 26.59 | 22814378 | |
6 | Acetylation | --MSVFGKLFGAGGG --CCHHHHCCCCCCC | 29.22 | 19608861 | |
6 | Ubiquitination | --MSVFGKLFGAGGG --CCHHHHCCCCCCC | 29.22 | 23000965 | |
14 | Ubiquitination | LFGAGGGKAGKGGPT CCCCCCCCCCCCCCC | 58.18 | 33845483 | |
14 | Acetylation | LFGAGGGKAGKGGPT CCCCCCCCCCCCCCC | 58.18 | 25953088 | |
17 | Acetylation | AGGGKAGKGGPTPQE CCCCCCCCCCCCHHH | 66.60 | 26051181 | |
17 | Ubiquitination | AGGGKAGKGGPTPQE CCCCCCCCCCCCHHH | 66.60 | 33845483 | |
17 | Malonylation | AGGGKAGKGGPTPQE CCCCCCCCCCCCHHH | 66.60 | 26320211 | |
35 | Sulfoxidation | RLRDTEEMLSKKQEF HHHHHHHHHHHHHHH | 4.10 | 21406390 | |
38 | Ubiquitination | DTEEMLSKKQEFLEK HHHHHHHHHHHHHHH | 55.29 | 32015554 | |
38 | Succinylation | DTEEMLSKKQEFLEK HHHHHHHHHHHHHHH | 55.29 | 23954790 | |
55 | Acetylation | EQELTAAKKHGTKNK HHHHHHHHHHCCHHH | 42.72 | 26051181 | |
55 | Ubiquitination | EQELTAAKKHGTKNK HHHHHHHHHHCCHHH | 42.72 | 32015554 | |
70 | Ubiquitination | RAALQALKRKKRYEK HHHHHHHHHHHHHHH | 66.25 | 32015554 | |
70 | 2-Hydroxyisobutyrylation | RAALQALKRKKRYEK HHHHHHHHHHHHHHH | 66.25 | - | |
87 | Phosphorylation | AQIDGTLSTIEFQRE HHCCCCHHHHHHHHH | 27.46 | - | |
101 | Phosphorylation | EALENANTNTEVLKN HHHHHCCCCHHHHHH | 40.90 | 25072903 | |
103 | Phosphorylation | LENANTNTEVLKNMG HHHCCCCHHHHHHHH | 25.98 | 25072903 | |
107 | Ubiquitination | NTNTEVLKNMGYAAK CCCHHHHHHHHHHHH | 50.49 | 23000965 | |
111 | Phosphorylation | EVLKNMGYAAKAMKA HHHHHHHHHHHHHHH | 7.82 | 28102081 | |
114 | Acetylation | KNMGYAAKAMKAAHD HHHHHHHHHHHHHHH | 40.62 | 19608861 | |
114 | Ubiquitination | KNMGYAAKAMKAAHD HHHHHHHHHHHHHHH | 40.62 | 32015554 | |
117 | Methylation | GYAAKAMKAAHDNMD HHHHHHHHHHHHCCC | 47.48 | - | |
184 | Phosphorylation | DKNLLEISGPETVPL HHHCHHHHCCCCCCC | 38.63 | 29255136 | |
188 | Phosphorylation | LEISGPETVPLPNVP HHHHCCCCCCCCCCC | 30.47 | 29255136 | |
196 | Phosphorylation | VPLPNVPSIALPSKP CCCCCCCCCCCCCCC | 19.06 | 29514088 | |
201 | Phosphorylation | VPSIALPSKPAKKKE CCCCCCCCCCCCCCC | 52.72 | 29514088 | |
202 | Ubiquitination | PSIALPSKPAKKKEE CCCCCCCCCCCCCCC | 47.24 | 22817900 | |
202 | Acetylation | PSIALPSKPAKKKEE CCCCCCCCCCCCCCC | 47.24 | 23954790 | |
205 | Ubiquitination | ALPSKPAKKKEEEDD CCCCCCCCCCCCCCC | 73.27 | 22817900 | |
206 | Ubiquitination | LPSKPAKKKEEEDDD CCCCCCCCCCCCCCH | 68.47 | 22817900 | |
207 | Ubiquitination | PSKPAKKKEEEDDDM CCCCCCCCCCCCCHH | 70.43 | 22817900 | |
223 | Phosphorylation | ELENWAGSM------ HHHHHHHCC------ | 17.36 | 28355574 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CHM4B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CHM4B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHM4B_HUMAN !! |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6 AND LYS-114, AND MASSSPECTROMETRY. |